Agree, but is't not at all diverse regarding experience. Again, really nobody has the medical-marketing-sales, market access or launch background. Really nobody!
It's all scientists, regulatory and clin development. Now it's time to go to the next phase, streamline the communications and have good activities with external experts and other stakeholders. There is a lack of focus, external relations and consistency in the story. They are not really aiming to bring the drug to the market ASAP. This is a scientist who doesn't know how to bring something new to the market.
Market Data 
Markets 
AI
